Nurse Practitioner, Family · Sherwood, AR
NPI
1215596168
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2215 Wildwood Ave Ste 208
Sherwood, AR, 72120
Phone (501) 552-7570
Groups this clinician bills Medicare through
Medicare paid, 2024
$120K
5,768 services
Medicare patients, 2024
339
Average age 71
Drug cost, 2024
$3.7M
7,451 prescriptions
Company payments, 2025
$954
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Megan B Kellar was code J0897 (injection, denosumab, 1 mg), 1,560 times for 24 patients. In total Megan B Kellar billed 5,768 services in 49 codes, and Medicare paid $120K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,560 | 24 | $21.30 | $33K |
| 99214 Office E&M - Established | Office | 718 | 311 | $61.24 | $44K |
| 36415 Venipuncture Blood Collection | Office | 378 | 268 | $8.45 | $3,195 |
| 83036 Blood Count | Office | 352 | 235 | $9.08 | $3,195 |
| 95251 Test - Miscellaneous | Office | 327 | 131 | $19.88 | $6,500 |
| 82962 Clinical Chemistry | Office | 253 | 198 | $3.04 | $770 |
| 84439 Clinical Chemistry | Office | 237 | 164 | $8.65 | $2,051 |
| 84443 Clinical Chemistry | Office | 237 | 164 | $16.18 | $3,834 |
| 82306 Clinical Chemistry | Office | 163 | 121 | $28.41 | $4,632 |
| 80053 Clinical Chemistry | Office | 147 | 116 | $10.24 | $1,506 |
| 80061 Clinical Chemistry | Office | 98 | 87 | $12.92 | $1,266 |
| 84480 Clinical Chemistry | Office | 68 | 47 | $13.57 | $923 |
| 85025 Blood Count | Office | 49 | 41 | $7.61 | $373 |
| 82043 Clinical Chemistry | Office | 39 | 38 | $5.55 | $216 |
| 82570 Clinical Chemistry | Office | 39 | 38 | $4.98 | $194 |
By year: 2022 $70K for 2,891 services; 2023 $59K for 2,257 services; 2024 $120K for 5,768 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 378 | 268 | $8.45 | $3,195 |
| 83036 Blood Count | 352 | 235 | $9.08 | $3,195 |
| 82962 Clinical Chemistry | 253 | 198 | $3.04 | $770 |
| 84439 Clinical Chemistry | 237 | 164 | $8.65 | $2,051 |
| 84443 Clinical Chemistry | 237 | 164 | $16.18 | $3,834 |
| 82306 Clinical Chemistry | 163 | 121 | $28.41 | $4,632 |
| 80053 Clinical Chemistry | 147 | 116 | $10.24 | $1,506 |
| 80061 Clinical Chemistry | 98 | 87 | $12.92 | $1,266 |
| 84480 Clinical Chemistry | 68 | 47 | $13.57 | $923 |
| 85025 Blood Count | 49 | 41 | $7.61 | $373 |
Medicare prescription drug claims, 2024
In 2024, the drug Megan B Kellar prescribed most often to Medicare patients was Ozempic (Semaglutide), with 899 prescriptions and refills. In total Megan B Kellar wrote 7,451 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 899 | 1,082 | 161 | $1.0M |
| Mounjaro Tirzepatide | 881 | 1,051 | 141 | $1.1M |
| Levothyroxine Sodium Generic | 565 | 1,102 | 116 | $4,556 |
| Jardiance Empagliflozin | 370 | 574 | 77 | $336K |
| Glimepiride Generic | 369 | 771 | 103 | $4,052 |
| Metformin Hcl Er Metformin Hcl | 239 | 580 | 80 | $3,062 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 201 | 295 | 44 | $49K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 201 | 336 | 41 | $197K |
| Tresiba Flextouch U-200 Insulin Degludec | 170 | 332 | 49 | $122K |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 168 | 282 | 46 | $52K |
| Synthroid Levothyroxine Sodium | 151 | 280 | 35 | $9,905 |
| Atorvastatin Calcium Generic | 151 | 270 | 35 | $1,082 |
| Pioglitazone Hcl Generic | 148 | 255 | 34 | $2,315 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 142 | 314 | 62 | $15K |
| Metformin Hcl Generic | 111 | 215 | 29 | $861 |
Brand drugs: 4,542 claims; generic drugs: 2,322 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Megan B Kellar $954 ($954 in general payments such as food, travel and fees) from 11 companies. The largest payer was Medtronic, Inc. with $345.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 13 | $345 |
| Insulet Corporation PODD | 7 | $141 |
| Novo Nordisk Inc NVO | 11 | $138 |
| Lilly USA, LLC LLY | 5 | $97.7 |
| Dexcom, Inc. DXCM | 2 | $54.36 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $50.36 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $39.53 |
| Abbott Laboratories ABT | 2 | $36.5 |
| Xeris Pharmaceuticals, Inc. | 1 | $19.78 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $17.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.